SOLANA BEACH, Calif-Officials at Futura Medical Corporation, a leader the sharps safety device industry, has entered a three-year product agreement with supply chain management leader Broadlane Inc.
The agreement, which took effect January 1, will potentially combine Broadlane's customer base of more than 300 acute care hospitals and more than 1,400 sub-acute care facilities and Futura's line of retracting safety scalpels.
Broadlane's customers include: Kaiser Permanente, Tenet Healthcare Corporation, Universal Health Services, Continuum Health partners, Community Health Systems, US Oncology, IASIS Healthcare, and MedCath Inc.
Futura manufactures the only automated retractable scalpel on the market.
Building Infection Prevention Capacity in the Middle East: A 7-Year Certification Success Story
June 17th 2025Despite rapid development, the Middle East faces a critical shortage of certified infection preventionists. A 7-year regional initiative has significantly boosted infection control capacity, increasing the number of certified professionals and elevating patient safety standards across health care settings.
Streamlined IFU Access Boosts Infection Control and Staff Efficiency
June 17th 2025A hospital-wide quality improvement project has transformed how staff access critical manufacturer instructions for use (IFUs), improving infection prevention compliance and saving time through a standardized, user-friendly digital system supported by unit-based training and interdepartmental collaboration.
Swift Isolation Protocol Shields Chicago Children’s Hospital During 2024 Measles Surge
June 17th 2025When Chicago logged its first measles cases linked to crowded migrant shelters last spring, one pediatric hospital moved in hours—not days—to prevent the virus from crossing its threshold. Their playbook offers a ready template for the next communicable-disease crisis.
Back to Basics: Hospital Restores Catheter-Associated UTI Rates to Prepandemic Baseline
June 16th 2025A 758-bed quaternary medical center slashed catheter-associated urinary tract infections (CAUTIs) by 45% over 2 years, proving that disciplined adherence to fundamental prevention steps, not expensive add-ons, can reverse the pandemic-era spike in device-related harm.